Half of Chronic Kidney Disease Cases Remain Undiagnosed Globally

A landmark Lancet series has revealed that nearly half of the estimated 844 million cases of chronic kidney disease (CKD) worldwide currently go undiagnosed. Despite the availability of simple, cost-effective urine tests, the silent progression of the illness often delays clinical detection until advanced stages, where interventions are significantly less effective. The study highlights that the condition has risen to become the ninth leading cause of death globally, necessitating a shift toward proactive community screening protocols.

The high rate of undiagnosed cases stems from the asymptomatic nature of early-stage kidney disease, which often mimics other conditions or presents no observable symptoms until major organ failure begins. Public health systems frequently lack the infrastructure to integrate routine kidney health monitoring into general check-ups, even for populations at risk due to diabetes or hypertension. Lack of awareness among both patients and primary healthcare providers compounds the issue, leading to missed opportunities for timely management that could prevent end-stage renal disease.

This finding emphasizes the urgent need for structural improvements in global primary healthcare, particularly in low- and middle-income countries where diagnostic resources are often scarce. India must prioritize the integration of kidney health monitoring into national wellness programmes to address the rising burden of non-communicable diseases. Experts advocate for universal screening protocols for high-risk individuals, as early medical management can effectively slow disease progression and reduce the growing pressure on national dialysis and transplant infrastructure.